Directed differentiation of human embryonic stem cells towards a pancreatic cell fate

J. H. Shim, S. E. Kim, D. H. Woo, S. K. Kim, Chil Hwan Oh, R. McKay, Jong-Hoon Kim

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Aims/hypothesis: The relative lack of successful pancreatic differentiation of human embryonic stem cells (hESCs) may suggest that directed differentiation of hESCs into definitive endoderm and subsequent commitment towards a pancreatic fate are not readily achieved. The aim of this study was to investigate whether sequential exposure of hESCs to epigenetic signals that mimic in vivo pancreatic development can efficiently generate pancreatic endodermal cells, and whether these cells can be further matured and reverse hyperglycaemia upon transplantation. Materials and methods: The hESCs were sequentially treated with serum, activin and retinoic acid (RA) during embryoid body formation. The patterns of gene expression and protein production associated with embryonic germ layers and pancreatic endoderm were analysed by RT-PCR and immunostaining. The developmental competence and function of hESC-derived PDX1-positive cells were evaluated after in vivo transplantation. Results: Sequential treatment with serum, activin and RA highly upregulated the expression of the genes encoding forkhead box protein A2 (FOXA2), SRY-box containing gene 17 (SOX17), pancreatic and duodenal homeobox 1 (PDX1) and homeobox HB9 (HLXB9). The population of pancreatic endodermal cells that produced PDX1 was significantly increased at the expense of ectodermal differentiation, and a subset of the PDX1-positive cells also produced FOXA2, caudal-type homeobox transcription factor 2 (CDX2), and nestin (NES). After transplantation, the PDX1-positive cells further differentiated into mature cell types producing insulin and glucagon, resulting in amelioration of hyperglycaemia and weight loss in streptozotocin-treated diabetic mice. Conclusions/interpretation: Our strategy allows the progressive differentiation of hESCs into pancreatic endoderm capable of generating mature pancreatic cell types that function in vivo. These findings may establish the basis of further investigations for the purification of transplantable islet progenitors derived from hESCs.

Original languageEnglish
Pages (from-to)1228-1238
Number of pages11
JournalDiabetologia
Volume50
Issue number6
DOIs
Publication statusPublished - 2007 Jun 1

Fingerprint

Homeobox Genes
Endoderm
Activins
Transplantation
Tretinoin
Hyperglycemia
Hepatocyte Nuclear Factor 3-beta
Embryoid Bodies
Gene Expression
Germ Layers
Nestin
Human Embryonic Stem Cells
Streptozocin
Glucagon
Serum
Epigenomics
Mental Competency
Weight Loss
Insulin
Polymerase Chain Reaction

Keywords

  • Activin
  • Differentiation
  • Embryoid bodies
  • Endoderm
  • Human embryonic stem cells
  • Hyperglycaemia
  • PDX1
  • Retinoic acid
  • Serum

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. / Shim, J. H.; Kim, S. E.; Woo, D. H.; Kim, S. K.; Oh, Chil Hwan; McKay, R.; Kim, Jong-Hoon.

In: Diabetologia, Vol. 50, No. 6, 01.06.2007, p. 1228-1238.

Research output: Contribution to journalArticle

Shim, J. H. ; Kim, S. E. ; Woo, D. H. ; Kim, S. K. ; Oh, Chil Hwan ; McKay, R. ; Kim, Jong-Hoon. / Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. In: Diabetologia. 2007 ; Vol. 50, No. 6. pp. 1228-1238.
@article{858e23a9552049f7ba2b5a1d3bdbd6d2,
title = "Directed differentiation of human embryonic stem cells towards a pancreatic cell fate",
abstract = "Aims/hypothesis: The relative lack of successful pancreatic differentiation of human embryonic stem cells (hESCs) may suggest that directed differentiation of hESCs into definitive endoderm and subsequent commitment towards a pancreatic fate are not readily achieved. The aim of this study was to investigate whether sequential exposure of hESCs to epigenetic signals that mimic in vivo pancreatic development can efficiently generate pancreatic endodermal cells, and whether these cells can be further matured and reverse hyperglycaemia upon transplantation. Materials and methods: The hESCs were sequentially treated with serum, activin and retinoic acid (RA) during embryoid body formation. The patterns of gene expression and protein production associated with embryonic germ layers and pancreatic endoderm were analysed by RT-PCR and immunostaining. The developmental competence and function of hESC-derived PDX1-positive cells were evaluated after in vivo transplantation. Results: Sequential treatment with serum, activin and RA highly upregulated the expression of the genes encoding forkhead box protein A2 (FOXA2), SRY-box containing gene 17 (SOX17), pancreatic and duodenal homeobox 1 (PDX1) and homeobox HB9 (HLXB9). The population of pancreatic endodermal cells that produced PDX1 was significantly increased at the expense of ectodermal differentiation, and a subset of the PDX1-positive cells also produced FOXA2, caudal-type homeobox transcription factor 2 (CDX2), and nestin (NES). After transplantation, the PDX1-positive cells further differentiated into mature cell types producing insulin and glucagon, resulting in amelioration of hyperglycaemia and weight loss in streptozotocin-treated diabetic mice. Conclusions/interpretation: Our strategy allows the progressive differentiation of hESCs into pancreatic endoderm capable of generating mature pancreatic cell types that function in vivo. These findings may establish the basis of further investigations for the purification of transplantable islet progenitors derived from hESCs.",
keywords = "Activin, Differentiation, Embryoid bodies, Endoderm, Human embryonic stem cells, Hyperglycaemia, PDX1, Retinoic acid, Serum",
author = "Shim, {J. H.} and Kim, {S. E.} and Woo, {D. H.} and Kim, {S. K.} and Oh, {Chil Hwan} and R. McKay and Jong-Hoon Kim",
year = "2007",
month = "6",
day = "1",
doi = "10.1007/s00125-007-0634-z",
language = "English",
volume = "50",
pages = "1228--1238",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Directed differentiation of human embryonic stem cells towards a pancreatic cell fate

AU - Shim, J. H.

AU - Kim, S. E.

AU - Woo, D. H.

AU - Kim, S. K.

AU - Oh, Chil Hwan

AU - McKay, R.

AU - Kim, Jong-Hoon

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Aims/hypothesis: The relative lack of successful pancreatic differentiation of human embryonic stem cells (hESCs) may suggest that directed differentiation of hESCs into definitive endoderm and subsequent commitment towards a pancreatic fate are not readily achieved. The aim of this study was to investigate whether sequential exposure of hESCs to epigenetic signals that mimic in vivo pancreatic development can efficiently generate pancreatic endodermal cells, and whether these cells can be further matured and reverse hyperglycaemia upon transplantation. Materials and methods: The hESCs were sequentially treated with serum, activin and retinoic acid (RA) during embryoid body formation. The patterns of gene expression and protein production associated with embryonic germ layers and pancreatic endoderm were analysed by RT-PCR and immunostaining. The developmental competence and function of hESC-derived PDX1-positive cells were evaluated after in vivo transplantation. Results: Sequential treatment with serum, activin and RA highly upregulated the expression of the genes encoding forkhead box protein A2 (FOXA2), SRY-box containing gene 17 (SOX17), pancreatic and duodenal homeobox 1 (PDX1) and homeobox HB9 (HLXB9). The population of pancreatic endodermal cells that produced PDX1 was significantly increased at the expense of ectodermal differentiation, and a subset of the PDX1-positive cells also produced FOXA2, caudal-type homeobox transcription factor 2 (CDX2), and nestin (NES). After transplantation, the PDX1-positive cells further differentiated into mature cell types producing insulin and glucagon, resulting in amelioration of hyperglycaemia and weight loss in streptozotocin-treated diabetic mice. Conclusions/interpretation: Our strategy allows the progressive differentiation of hESCs into pancreatic endoderm capable of generating mature pancreatic cell types that function in vivo. These findings may establish the basis of further investigations for the purification of transplantable islet progenitors derived from hESCs.

AB - Aims/hypothesis: The relative lack of successful pancreatic differentiation of human embryonic stem cells (hESCs) may suggest that directed differentiation of hESCs into definitive endoderm and subsequent commitment towards a pancreatic fate are not readily achieved. The aim of this study was to investigate whether sequential exposure of hESCs to epigenetic signals that mimic in vivo pancreatic development can efficiently generate pancreatic endodermal cells, and whether these cells can be further matured and reverse hyperglycaemia upon transplantation. Materials and methods: The hESCs were sequentially treated with serum, activin and retinoic acid (RA) during embryoid body formation. The patterns of gene expression and protein production associated with embryonic germ layers and pancreatic endoderm were analysed by RT-PCR and immunostaining. The developmental competence and function of hESC-derived PDX1-positive cells were evaluated after in vivo transplantation. Results: Sequential treatment with serum, activin and RA highly upregulated the expression of the genes encoding forkhead box protein A2 (FOXA2), SRY-box containing gene 17 (SOX17), pancreatic and duodenal homeobox 1 (PDX1) and homeobox HB9 (HLXB9). The population of pancreatic endodermal cells that produced PDX1 was significantly increased at the expense of ectodermal differentiation, and a subset of the PDX1-positive cells also produced FOXA2, caudal-type homeobox transcription factor 2 (CDX2), and nestin (NES). After transplantation, the PDX1-positive cells further differentiated into mature cell types producing insulin and glucagon, resulting in amelioration of hyperglycaemia and weight loss in streptozotocin-treated diabetic mice. Conclusions/interpretation: Our strategy allows the progressive differentiation of hESCs into pancreatic endoderm capable of generating mature pancreatic cell types that function in vivo. These findings may establish the basis of further investigations for the purification of transplantable islet progenitors derived from hESCs.

KW - Activin

KW - Differentiation

KW - Embryoid bodies

KW - Endoderm

KW - Human embryonic stem cells

KW - Hyperglycaemia

KW - PDX1

KW - Retinoic acid

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=34247898958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247898958&partnerID=8YFLogxK

U2 - 10.1007/s00125-007-0634-z

DO - 10.1007/s00125-007-0634-z

M3 - Article

VL - 50

SP - 1228

EP - 1238

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -